News & Updates

Show Multimedia Only

Drainage through ERCP, PTBD acceptable for preparing patients for curative HC resection

07 Oct 2021

Endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic biliary drainage (PTBD), either alone or in combination, are acceptable for the preoperative management of hilar cholangiocarcinoma (HC) and can help optimize patients for curative HC resection, a recent study has found.

Drainage through ERCP, PTBD acceptable for preparing patients for curative HC resection

07 Oct 2021

Acid suppression drugs counteract EGFR-TKIs for NSCLC treatment

07 Oct 2021 by

Acid suppression (AS) medications, such as proton pump inhibitors (PPIs) and histamine type-2 receptor antagonists (H2RAs), weaken the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in nonsmall cell lung cancer (NSCLC), resulting in worse survival outcomes, according to a recent Singapore meta-analysis.

Acid suppression drugs counteract EGFR-TKIs for NSCLC treatment

07 Oct 2021

CV safety of degarelix vs leuprolide: Results remain inconclusive

06 Oct 2021 by

In men with prostate cancer and concomitant atherosclerotic cardiovascular disease (ASCVD), major adverse cardiovascular event (MACE) incidence did not differ between those who were treated with degarelix or leuprolide, according to findings of the PRONOUNCE trial.

CV safety of degarelix vs leuprolide: Results remain inconclusive

06 Oct 2021

News & Updates

Showing Oncology articles

Showing

Specialty:

Drainage through ERCP, PTBD acceptable for preparing patients for curative HC resection

Acid suppression drugs counteract EGFR-TKIs for NSCLC treatment

CV safety of degarelix vs leuprolide: Results remain inconclusive